RPS6KB1 and cancer: In Figs 5 and 6 (also depicted in Supplementary Table 6), the enrichment analyses revealed several biological pathways potentially implicated for the identified proteins (NEFL, RPS6KB1, KIM1, EDA2R and MMP12), including the immune system, cancers and insulin signaling.